<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Supernus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company currently markets Trokendi XRÂŽ (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XRÂŽ (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-810 for the treatment of Impulsive Aggression in ADHD patients, SPN-812 for the treatment of ADHD and SPN-604 for the treatment of bipolar disorder. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jack A. Khattar
    • FOUNDED
      2005
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Generex Biotechnology Corp.

    Generex Biotechnology Corp.

    Generex Biotechnology is an integrated healthcare holding company with end-to-end ...

    Generex Biotechnology is an integrated healthca...

    Filing Type:    PU
    Opiant Pharmaceuticals, Inc.

    Opiant Pharmaceuticals, Inc.

    Opiant is a specialty pharmaceutical company developing medicines for addiction an...

    Opiant is a specialty pharmaceutical company de...

    Filing Type:    PU
    ICU Medical, Inc.

    ICU Medical, Inc.

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medica...

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manuf...

    Filing Type:    PU
    aTyr Pharma, Inc.

    aTyr Pharma, Inc.

    aTyr’s mission is to translate newly discovered biological pathways to develop i...

    aTyr’s mission is to translate newly discover...

    Filing Type:    PU
    TFF Pharmaceuticals, Inc.

    TFF Pharmaceuticals, Inc.

    Although intended for the lungs, many drugs are not given via the airway because d...

    Although intended for the lungs, many drugs are...

    Filing Type:    PU
    Sophiris Bio, Inc.

    Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin ...

    Sophiris Bio Inc. is a late-stage biopharmaceut...

    Filing Type:    PU
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...

    Filing Type:    PU
    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing...

    Axsome Therapeutics, Inc. is a clinical-stage b...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.